TherapeuticsMD Inc. (NASDAQ: TXMD) Stock Information | RedChip

TherapeuticsMD Inc. (NASDAQ: TXMD) Listen to this Section


$1.62
-0.0060 ( -0.37% ) 8.6K

TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.

Market Data


Open


$1.62

Previous close


$1.63

Volume


8.6K

Market cap


$18.57M

Day range


$1.61 - $1.70

52 week range


$1.43 - $4.03

Insider Ownership Transactions

Total Amount Purchased: -954,692.00 | $ -1,546,601.04

Date Type Amount Purchased Purchaser
2023-12-07 Sale -70000.00 Walker Marlan D
2023-11-17 Sale -877192.00 Rubric Capital Management LP
2023-08-21 Sale -7500.00 ZIEGLER JOSEPH

SEC Fillings


Form Type Description Pages Date
10-q Quarterly Reports 65 Aug 12, 2024
8-k 8K-related 15 Aug 12, 2024
8-k 8K-related 16 May 10, 2024
10-q Quarterly Reports 65 May 10, 2024
10-k/a Quarterly Reports 17 Apr 29, 2024
10-k Annual reports 89 Mar 29, 2024
8-k 8K-related 15 Mar 29, 2024
4 Insider transactions 1 Dec 07, 2023
4 Insider transactions 1 Nov 17, 2023
8-k 8K-related 14 Nov 14, 2023

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.